Mather Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mather Group’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$24.9K	Buy	66 +8	+14%	+$2.79K	﹤0.01%	1378
2026 Q2	$17K	Hold	58	–	–	﹤0.01%	1367
2026 Q1	$16.2K	Buy	+58	New	+$16.7K	﹤0.01%	1334
2025 Q4	–	Sell	-58	Closed	-$16.3K	–	761
2025 Q3	$16.3K	Buy	+58	New	+$15.8K	﹤0.01%	1162
2025 Q2	–	Sell	-311	Closed	-$75.7K	–	732
2025 Q1	$75.7K	Sell	311 -150	-33%	-$45.1K	﹤0.01%	820
2024 Q4	$151K	Buy	461 +292	+173%	+$99.1K	﹤0.01%	650
2024 Q3	$56.5K	Sell	169 -191	-53%	-$60.7K	﹤0.01%	856
2024 Q2	$125K	Buy	360 +100	+38%	+$29.1K	﹤0.01%	745
2024 Q1	$84K	Buy	+260	New	+$85.5K	﹤0.01%	754
2023 Q2	–	Sell	-520	Closed	-$249K	–	622
2023 Q1	$249K	Buy	520 +3	+0.6%	+$1.4K	﹤0.01%	436
2022 Q4	$217K	Buy	+517	New	+$209K	﹤0.01%	449
2022 Q3	–	Sell	-421	Closed	-$208K	–	471
2022 Q2	$208K	Buy	421 +44	+12%	+$22.9K	﹤0.01%	361
2022 Q1	$212K	Buy	377 +24	+7%	+$14.5K	﹤0.01%	419
2021 Q4	$267K	Sell	353 -15	-4%	-$11.2K	0.01%	317
2021 Q3	$275K	Sell	368 -20	-5%	-$15K	0.01%	236
2021 Q2	$250K	Sell	388 -5	-1%	-$3.04K	0.01%	239
2021 Q1	$224K	Buy	393 +1	+0.3%	+$592	0.01%	241
2020 Q4	$229K	Buy	392 +3	+0.8%	+$1.71K	0.01%	220
2020 Q3	$201K	Buy	+389	New	+$197K	0.01%	232

Other funds holding BIO

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Focused Alpha LLC Denver, Colorado $402M AUM 23.92% 1-Year Est. Return

Mather Group's BIO Position: Q3 2026 in Review

Mather Group increased its Bio-Rad Laboratories Class A (BIO) stake by 14% in Q3 2026, buying an estimated $2.79K and bringing the position to 66 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

Mather Group first reported a position in BIO in Q3 2020 and has held it in 19 quarters since. The position peaked at $275K in Q3 2021. 67 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

Mather Group held 66 shares of Bio-Rad Laboratories Class A worth $24.9K as of Q3 2026.
Mather Group bought 8 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $2.79K.
Bio-Rad Laboratories Class A made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1378 holding.
Mather Group first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and has held it in 19 quarters since.
Mather Group's Bio-Rad Laboratories Class A position peaked at $275K in Q3 2021.
67 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.